Diane Rindgen

1.9k total citations
24 papers, 894 citations indexed

About

Diane Rindgen is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Diane Rindgen has authored 24 papers receiving a total of 894 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Oncology and 9 papers in Organic Chemistry. Recurrent topics in Diane Rindgen's work include Chemokine receptors and signaling (6 papers), Multicomponent Synthesis of Heterocycles (4 papers) and Bioactive Compounds and Antitumor Agents (3 papers). Diane Rindgen is often cited by papers focused on Chemokine receptors and signaling (6 papers), Multicomponent Synthesis of Heterocycles (4 papers) and Bioactive Compounds and Antitumor Agents (3 papers). Diane Rindgen collaborates with scholars based in United States, China and United Kingdom. Diane Rindgen's co-authors include Ian A. Blair, Masaharu Nakajima, Seon Hwa Lee, Nigel J. Clarke, Walter A. Korfmacher, Kathleen Cox, T.M. Penning, Paul Vouros, Suzanne Wehrli and Keyang Xu and has published in prestigious journals such as Analytical Chemistry, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Diane Rindgen

24 papers receiving 856 citations

Peers

Countries citing papers authored by Diane Rindgen

Since Specialization

Citations

This map shows the geographic impact of Diane Rindgen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diane Rindgen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diane Rindgen more than expected).

Fields of papers citing papers by Diane Rindgen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diane Rindgen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diane Rindgen. The network helps show where Diane Rindgen may publish in the future.

Co-authorship network of co-authors of Diane Rindgen

This figure shows the co-authorship network connecting the top 25 collaborators of Diane Rindgen. A scholar is included among the top collaborators of Diane Rindgen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diane Rindgen. Diane Rindgen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery of a highly potent orally bioavailable imidazo-[1, 2-a]pyrazine Aurora inhibitor 2018 ·Bioorganic & Medicinal Chemistry Letters ·Tao Yu, Yonglian Zhang, Angela D. Kerekes, Jayaram R. Tagat, Ronald J. Doll, Yushi Xiao, (unknown), Alan Hruza, David Belanger, Matthew E. Voss, Matthew P. Rainka, Andrea Basso, Ming Liu, Lianzhu Liang, Ning Sui, (unknown), Diane Rindgen, Li‐Kang Zhang	4
2	Discovery of pyrrolo-benzo-1,4-diazines as potent Nav1.7 sodium channel blockers 2014 ·Bioorganic & Medicinal Chemistry Letters ·Ginny D. Ho, Deen Tulshian, (unknown), Zheng Tan, (unknown), (unknown), Julius J. Matasi, (unknown), William G. Earley, (unknown), R. Jason Herr, Xiaoping Zhou, (unknown), Diane Rindgen, Steve Sorota, Shu‐Wei Yang	10
3	Bioavailable pyrrolo-benzo-1,4-diazines as Nav1.7 sodium channel blockers for the treatment of pain 2014 ·Bioorganic & Medicinal Chemistry Letters ·Shu‐Wei Yang, Ginny D. Ho, Deen Tulshian, (unknown), Zheng Tan, (unknown), (unknown), Julius J. Matasi, Xianfeng Sun, (unknown), R. Jason Herr, Xiaoping Zhou, (unknown), Mark O. Urban, Jeffrey A. Vivian, Diane Rindgen, Steve Sorota	13
4	Design, Synthesis, and Evaluation of Prodrugs of Ertapenem 2013 ·ACS Medicinal Chemistry Letters ·Sheo B. Singh, Diane Rindgen, Prudence Bradley, L. D. Cama, Wanying Sun, Michael J. Hafey, Takao Suzuki, (unknown), Hao Wu, (unknown), Li Wang, (unknown), Hongshi Yu, Richard Söll, David B. Olsen, Peter T. Meinke, Deborah A. Nicoll‐Griffith	7
5	The SAR development of dihydroimidazoisoquinoline derivatives as phosphodiesterase 10A inhibitors for the treatment of schizophrenia 2012 ·Bioorganic & Medicinal Chemistry Letters ·Ginny D. Ho, W. Michael Seganish, (unknown), Deen Tulshian, William J. Greenlee, (unknown), Alan Hruza, Li Xiao, Diane Rindgen, Deborra Mullins, M. Guzzi, Xiaoping Zhang, (unknown), Robert A. Hodgson	20
6	The discovery of potent, selective, and orally active pyrazoloquinolines as PDE10A inhibitors for the treatment of Schizophrenia 2011 ·Bioorganic & Medicinal Chemistry Letters ·Ginny D. Ho, Shu‐Wei Yang, (unknown), (unknown), Terry L. Nechuta, Elizabeth M. Smith, William T. McElroy, Zheng Tan, Deen Tulshian, Brian A. McKittrick, William J. Greenlee, Alan Hruza, Xiao Li, Diane Rindgen, Deborra Mullins, M. Guzzi, Xiaoping Zhang, (unknown), Robert A. Hodgson	28
7	Discovery of orally active pyrazoloquinolines as potent PDE10 inhibitors for the management of schizophrenia 2011 ·Bioorganic & Medicinal Chemistry Letters ·Shu‐Wei Yang, (unknown), William T. McElroy, Zheng Tan, Ginny D. Ho, Deen Tulshian, William J. Greenlee, M. Guzzi, Xiaoping Zhang, Deborra Mullins, Li Xiao, Alan Hruza, Tze‐Ming Chan, Diane Rindgen, (unknown), Robert A. Hodgson	43
8	Fluoroalkyl α side chain containing 3,4-diamino-cyclobutenediones as potent and orally bioavailable CXCR2–CXCR1 dual antagonists 2009 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Arthur G. Taveras, Michael P. Dwyer, Younong Yu, Jianhua Chao, R. William Hipkin, Xuedong Fan, Diane Rindgen, Jay S. Fine, Daniel Lundell	13
9	Diaminocyclobutenediones as potent and orally bioavailable CXCR2 receptor antagonists: SAR in the phenolic amide region 2009 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Jianping Chao, (unknown), Michael P. Dwyer, Younong Yu, Jianhua Chao, (unknown), (unknown), (unknown), R. William Hipkin, Xuedong Fan, Waldemar Gonsiorek, (unknown), Diane Rindgen, Jay S. Fine, Daniel Lundell, Arthur G. Taveras, (unknown)	8
10	Synthesis and structure–activity relationships of new disubstituted phenyl-containing 3,4-diamino-3-cyclobutene-1,2-diones as CXCR2 receptor antagonists 2008 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), J. Robert Merritt, (unknown), Daming Feng, Jianhua Chao, Michael Czarniecki, Laura L. Rokosz, Tara M. Stauffer, Diane Rindgen, Arthur G. Taveras	8
11	Spiro-piperidine azetidinones as potent TRPV1 antagonists 2008 ·Bioorganic & Medicinal Chemistry Letters ·Dong Xiao, Anandan Palani, Robert Aslanian, Brian A. McKittrick, Andrew T. McPhail, Craig C. Correll, (unknown), John C. Anthes, Diane Rindgen	11
12	A Novel, Orally Active CXCR1/2 Receptor Antagonist, Sch527123, Inhibits Neutrophil Recruitment, Mucus Production, and Goblet Cell Hyperplasia in Animal Models of Pulmonary Inflammation 2007 ·Journal of Pharmacology and Experimental Therapeutics ·Richard W. Chapman, Michael Minnicozzi, Chander Celly, Jonathan E. Phillips, Ted T. Kung, R. William Hipkin, Xuedong Fan, Diane Rindgen, Gregory Deno, Richard Bond, Waldemar Gonsiorek, Motasim Billah, Jay S. Fine, John A. Hey	116
13	3,4-Diamino-2,5-thiadiazole-1-oxides as potent CXCR2/CXCR1 antagonists 2007 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Arthur G. Taveras, Younong Yu, Junying Zheng, Jianhua Chao, Diane Rindgen, James Jakway, R. William Hipkin, James Fossetta, Xuedong Fan, Jay S. Fine, Hongchen Qiu, J. Robert Merritt, John J. Baldwin	16
14	C(4)-alkyl substituted furanyl cyclobutenediones as potent, orally bioavailable CXCR2 and CXCR1 receptor antagonists 2007 ·Bioorganic & Medicinal Chemistry Letters ·Jianhua Chao, Arthur G. Taveras, Jianping Chao, (unknown), Michael P. Dwyer, Younong Yu, (unknown), Diane Rindgen, James Jakway, (unknown), (unknown), Xuedong Fan, Daniel Lundell, Jay S. Fine, Michael Minnicozzi, Jonathan E. Phillips, J. Robert Merritt	38
15	Isolation of circulating metabolites in drug discovery using high-performance liquid chromatography, and their identification by liquid chromatography coupled with tandem mass spectrometry and nuclear magnetic resonance spectroscopy 2002 ·Journal of Separation Science ·Hong Kim, Wenqing Feng, (unknown), Diane Rindgen, Matthew Bryant, Kathleen Cox, (unknown), Gregory A. Reichard, Sunil Paliwal, David Hesk, Jairam Palamanda, Ronald E. White, Amin A. Nomeir	2
16	Peer Reviewed: Systematic LC/MS Metabolite Identification in Drug Discovery 2001 ·Analytical Chemistry ·Nigel J. Clarke, Diane Rindgen, Walter A. Korfmacher, Kathleen Cox	103
17	Characterization of 2‘-Deoxyadenosine Adducts Derived from 4-Oxo-2-nonenal, a Novel Product of Lipid Peroxidation 2000 ·Chemical Research in Toxicology ·Seon Hwa Lee, Diane Rindgen, Roy H. Bible, (unknown), Ian A. Blair	85
18	Formation of a Substituted 1,N⁶-Etheno-2‘-deoxyadenosine Adduct by Lipid Hydroperoxide-Mediated Generation of 4-Oxo-2-nonenal 2000 ·Chemical Research in Toxicology ·Diane Rindgen, Seon Hwa Lee, Masaharu Nakajima, Ian A. Blair	54
19	Determination of in Vitro Formed DNA Adducts of 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine Using Capillary Liquid Chromatography/Electrospray Ionization/Tandem Mass Spectrometry 1995 ·Chemical Research in Toxicology ·Diane Rindgen, Robert J. Turesky, Paul Vouros	66
20	Mass spectrometric assay for determination of pancuronium and vecuronium in biological fluids utilizing the moving belt introduction system 1990 ·Journal of Mass Spectrometry ·Timothy R. Baker, Paul Vouros, Diane Rindgen, J. A. Jeevendra Martyn	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact